Jun-Ping Wei
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
- Oncology 15
- HER2/EGFR in Cancer Research 7
- CAR-T cell therapy research 3
- Cancer Immunotherapy and Biomarkers 3
- Immunology 10
- Immunotherapy and Immune Responses 6
- Co-authors
- Herbert Kim Lyerly (18 shared papers)Mark Wunderlich (6 shared papers)James C. Mulloy (6 shared papers)Gangjun Lei (15 shared papers)Zachary C. Hartman (15 shared papers)Michael Andrew Morse (10 shared papers)Hongtao Guo (6 shared papers)Yi Zheng (3 shared papers)
- Journals
- Blood (4 papers)Journal for ImmunoTherapy of Cancer (4 papers)Biochemical and Biophysical Research Communications (3 papers)JCI Insight (3 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- United StatesChinaBelgium
In The Last Decade
Jun-Ping Wei
42 papers receiving 1.5k citations
Jun-Ping Wei's Hit Papers
Peers
Comparison fields: 5 of 90
- Hematology 265
- Immunology 412
- Oncology 490
- Cancer Research 178
- Molecular Biology 708
Countries citing papers authored by Jun-Ping Wei
This map shows the geographic impact of Jun-Ping Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun-Ping Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun-Ping Wei more than expected).
Fields of papers citing papers by Jun-Ping Wei
This network shows the impact of papers produced by Jun-Ping Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun-Ping Wei. The network helps show where Jun-Ping Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun-Ping Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 279 | |
| 2 | 2011 | 174 | |
| 3 | 2019 | 90 | |
| 4 | 2009 | 88 | |
| 5 | 2012 | 86 | |
| 6 | Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd) Hit paper breakdown → | 2025 | 85 |
| 7 | 2017 | 62 | |
| 8 | 2011 | 61 | |
| 9 | 2008 | 58 | |
| 10 | 2004 | 45 | |
| 11 | 2020 | 43 | |
| 12 | 2006 | 41 | |
| 13 | 2004 | 41 | |
| 14 | 2022 | 36 | |
| 15 | 2012 | 32 | |
| 16 | 2021 | 28 | |
| 17 | 2020 | 26 | |
| 18 | 2010 | 26 | |
| 19 | 2008 | 23 | |
| 20 | 2017 | 23 |
About Jun-Ping Wei
Jun-Ping Wei is a scholar working on Oncology, Immunology, Hematology, Molecular Biology and Cancer Research, having authored 43 papers that have together received 1.6k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (7 papers), Acute Myeloid Leukemia Research (6 papers), Immunotherapy and Immune Responses (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Bone and Dental Protein Studies (4 papers), CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Hematology (265 citations), Immunology (412 citations), Oncology (490 citations), Cancer Research (178 citations) and Molecular Biology (708 citations). Jun-Ping Wei has collaborated with scholars based in United States, China and Belgium. Frequent co-authors include Herbert Kim Lyerly, Mark Wunderlich, James C. Mulloy, Gangjun Lei, Zachary C. Hartman, Michael Andrew Morse, Hongtao Guo, Yi Zheng, Takuya Osada and Amy C. Hobeika. Their work appears in journals such as Blood, Journal for ImmunoTherapy of Cancer, Biochemical and Biophysical Research Communications, JCI Insight and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.